Cardiosense

Cardiosense (operating at cardiosense.com) is a healthcare technology platform engineered for early detection and continuous monitoring of cardiac diseases. Founded in 2020 by Amit Gupta, Arash Kheradvar, Andrew Carek, and Omer Inan, and headquartered in Chicago, IL, Cardiosense redefines cardiac care by replacing traditional, invasive diagnostic methods with a seamless, noninvasive solution. Under the hood, the company leverages wearable technology, advanced signal processing, and deep learning to analyze physiological waveforms—including seismocardiogram (SCG) and electrocardiogram (ECG)—to develop predictive biomarkers. This allows clinicians to detect and manage cardiac conditions like heart failure with unprecedented precision, enabling proactive interventions before symptoms escalate. Backed by $15.2 million in funding from investors like Hatteras Venture Partners and Broadview Ventures, Cardiosense has also secured critical regulatory milestones, including FDA Breakthrough Device Designation and De Novo Classification, solidifying its position as a leader in AI-driven cardiac diagnostics.